DENTSPLY SIRONA Inc (NASDAQ:XRAY) saw unusually large options trading activity on Thursday. Traders purchased 3,364 put options on the stock. This represents an increase of approximately 1,209% compared to the average volume of 257 put options.

Shares of DENTSPLY SIRONA (XRAY) opened at $56.96 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. The firm has a market cap of $12,876.02, a PE ratio of -16.41, a price-to-earnings-growth ratio of 2.07 and a beta of 1.20. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $68.98.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.81 by $0.01. The firm had revenue of $1.09 billion for the quarter, compared to analysts’ expectations of $1.06 billion. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.67 earnings per share. sell-side analysts predict that DENTSPLY SIRONA will post 2.65 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Shareholders of record on Thursday, March 29th will be paid a dividend of $0.0875 per share. The ex-dividend date is Wednesday, March 28th. This represents a $0.35 annualized dividend and a yield of 0.61%. DENTSPLY SIRONA’s dividend payout ratio is -10.09%.

In related news, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $68.04, for a total value of $436,068.36. Following the sale, the director now owns 12,073 shares of the company’s stock, valued at $821,446.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.99% of the company’s stock.

Institutional investors have recently modified their holdings of the business. NuWave Investment Management LLC bought a new stake in DENTSPLY SIRONA during the fourth quarter worth about $121,000. Massey Quick Simon & CO. LLC bought a new stake in DENTSPLY SIRONA during the third quarter worth about $124,000. Focused Wealth Management Inc grew its stake in DENTSPLY SIRONA by 79.2% during the fourth quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock worth $171,000 after buying an additional 1,149 shares during the last quarter. Huntington National Bank bought a new stake in DENTSPLY SIRONA during the third quarter worth about $157,000. Finally, First Interstate Bank bought a new stake in DENTSPLY SIRONA during the third quarter worth about $164,000. 96.05% of the stock is currently owned by hedge funds and other institutional investors.

A number of analysts recently weighed in on the stock. Credit Suisse Group lowered their target price on shares of DENTSPLY SIRONA from $73.00 to $69.00 and set an “outperform” rating on the stock in a research note on Friday. BidaskClub cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday. HC Wainwright reissued a “hold” rating and issued a $68.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, January 18th. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, January 8th. Finally, JPMorgan Chase & Co. raised shares of DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 target price on the stock in a research note on Wednesday, December 13th. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $68.85.

TRADEMARK VIOLATION WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at


DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with's FREE daily email newsletter.